Literature DB >> 18062124

Fibrin adhesive derived from snake venom in periodontal surgery.

Mônica D S Barbosa1, Sebastião Luis A Gregh, Euloir Passanezi.   

Abstract

BACKGROUND: A new fibrin adhesive made of buffalo plasma-derived fibrinogen and a thrombin-like enzyme obtained from snake venom was evaluated in this case series with regard to its applicability in periodontal surgery. Free gingival grafts that were sutured (control group) were compared to others immobilized through the use of the adhesive (experimental group).
METHODS: The grafts were carried out in contralateral mandibular bicuspids of 15 patients so that each subject received one treatment of each type. The analysis included measurements of probing and vertical dimension of the grafts and photographic follow-up for 90 days. The patients answered a questionnaire concerning postoperative signs and symptoms.
RESULTS: The decrease in the vertical dimension of the grafts was significant during the first 30 days and more dramatic for the control group. Probing depth and attachment level presented statistically significant decreases for both groups. The grafts of the experimental group presented better appearance during the first 14 postoperative days. Pain was observed more often in the control group.
CONCLUSIONS: Within the limits of the present study, it is suggested that the alternative fibrin adhesive tested may represent an alternative to sutures in periodontal surgery. Nevertheless, randomized clinical trials should be performed to evaluate the clinical advantages and disadvantages of the material.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18062124     DOI: 10.1902/jop.2007.070005

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

1.  Animal venom studies: Current benefits and future developments.

Authors:  Yuri N Utkin
Journal:  World J Biol Chem       Date:  2015-05-26

2.  Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases.

Authors:  Helena Sandrini Venante; Ana Paula Chappuis-Chocano; Oscar Oswaldo Marcillo-Toala; Rafaela Alves da Silva; Rodrigo Moreira Bringel da Costa; Mariana Domingues Pordeus; Benedito Barraviera; Rui Seabra Ferreira Junior; Vanessa Soares Lara; Karin Hermana Neppelenbroek; Heitor Marques Honório; Vinicius Carvalho Porto
Journal:  Materials (Basel)       Date:  2021-03-26       Impact factor: 3.623

Review 3.  Multiple uses of fibrin sealant for nervous system treatment following injury and disease.

Authors:  Natalia Perussi Biscola; Luciana Politti Cartarozzi; Suzana Ulian-Benitez; Roberta Barbizan; Mateus Vidigal Castro; Aline Barroso Spejo; Rui Seabra Ferreira; Benedito Barraviera; Alexandre Leite Rodrigues Oliveira
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-03-14

Review 4.  Heterologous fibrin sealant derived from snake venom: from bench to bedside - an overview.

Authors:  Rui Seabra Ferreira; Luciana Curtolo de Barros; Luciana Patrícia Fernandes Abbade; Silvia Regina Catharino Sartori Barraviera; Maria Regina Cavariani Silvares; Leticia Gomes de Pontes; Lucilene Delazari Dos Santos; Benedito Barraviera
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-04-04

5.  Fibrin adhesive derived from snake venom in periodontal surgery: histological analysis.

Authors:  Mônica D S Barbosa; Antônio Carlos Stipp; Euloir Passanezi; Sebastião Luis A Greghi
Journal:  J Appl Oral Sci       Date:  2008 Sep-Oct       Impact factor: 2.698

6.  Autologous or heterologous fibrin sealant scaffold: which is the better choice?

Authors:  Rui Seabra Ferreira
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-07-18

7.  Long-Standing Motor and Sensory Recovery following Acute Fibrin Sealant Based Neonatal Sciatic Nerve Repair.

Authors:  Natalia Perussi Biscola; Luciana Politti Cartarozzi; Rui Seabra Ferreira Junior; Benedito Barraviera; Alexandre Leite Rodrigues de Oliveira
Journal:  Neural Plast       Date:  2016-06-29       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.